Clinical trial
Development of Multiphasic CT-based Delta-Radiomics Model for Predicting Postoperative Recurrence Risk in Bladder Cancer
NCT07251946 is registered in ClinicalTrials.gov with Lian Yang as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Development of Multiphasic CT-based Delta-Radiomics Model for Predicting Postoperative Recurrence Risk in Bladder Cancer
- Lead sponsor
- Lian Yang
- Phase
- Observational
- Overall status
- Completed
- Start date
- August 1, 2019
- Completion date
- March 31, 2023
- Enrollment
- 316 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
bladder cancer